Introduction-The emergence of a novel coronavirus, SARS-CoV-2, has highlighted the need for rapid, accurate, and point-of-care diagnostic testing. As of now, there is not enough testing capacity in the world to meet the stated testing targets, which are expected to skyrocket globally for broader testing during reopening Aim-This review focuses on the development of lab-on-chip biosensing platforms for diagnosis of COVID-19 infection. Results-We discuss advantages of utilizing lab-on-chip technologies in response to the current global pandemic, including their potential for low-cost, rapid sample-toanswer processing times, and ease of integration into a range of healthcare settings. We then highlight the development of magnetic, colorimetric, plasmonic, electrical, and lateral flow-based lab-on-chip technologies for the detection of SARS-CoV-2, in addition to other viruses. We focus on rapid, point-of-care technologies that can be deployed at scale, as such devices could be promising alternatives to the current gold standard of reverse transcription-polymerase chain reaction (RT-PCR) diagnostic testing. Conclusion-This review is intended to provide an overview of the current state-of-the-field and serve as a resource for innovative development of new lab-on-chip assays for COVID-19 detection.

Liquid biopsy, as a minimally invasive method of gleaning insight into the dynamics of diseases through a patient fluid sample, has been growing in popularity for cancer diagnosis, prognosis, and monitoring. While many technologies have been developed and validated in research laboratories, there has also been a push to expand these technologies into other clinical settings and as point of-care devices. In this review we discuss and evaluate microchip-based technologies for circulating tumor cell (CTC), exosome, and circulating tumor nucleic acid (ctNA) capture, detection, and analysis. Such integrated systems streamline otherwise multiple-step, manual operations to get a sample-to-answer quantitation. In addition, analysis of disease biomarkers is suited to point of care settings because of ease of use, low consumption of sample and reagents, and high throughput. We also cover the basics of biomarkers and their detection in biological fluid samples suitable for liquid biopsy on-chip. We focus on emerging technologies that process a small patient sample with high spatial-temporal resolution and derive clinically meaningful results through on-chip biomarker sensing and downstream molecular analysis in a simple workflow. This critical review is meant as a resource for those interested in developing technologies for capture, detection, and analysis platforms for liquid biopsy in a variety of settings.

No abstract

No abstract

This comprehensive review serves as a guide for developing scalable and robust liquid biopsies on chip for capture, detection, and analysis of circulating tumor cells (CTCs). Liquid biopsy, the detection of biomarkers from body fluids, has proven challenging because of CTC rarity and the heterogeneity of CTCs shed from tumors. The review starts with the underlying biological mechanisms that make liquid biopsy a challenge before moving into an evaluation of current technological progress. Then, a framework for evaluation of the technologies is presented with special attention to throughput, capture rate, and cell viability for analysis. Technologies for CTC capture, detection, and analysis will be evaluated based on these criteria, with a focus on current approaches, limitations and future directions. The paper provides a critical review for microchip developers as well as clinical investigators to build upon the existing progress towards the goal of designing CTC capture, detection, and analysis platforms.

Herein, a facile strategy was firstly developed to synthesize ellipsoidal mesoporous silica nanomaterials (MSNs) with well-ordered parallel channels along the short axis. A miniaturized microfluidic device with spiral-shaped channels was then chosen as a straightforward and general platform to produce the corresponding hollow counterparts of MSNs under mild conditions. Such reaction process carried out in a microfluidic system was further demonstrated to be more rapid and efficient than a conventional batch method under equivalent experimental conditions. The evolution of hollow structure can be well tuned by flow rates (i.e. etching time), providing a new paradigm for rational design and engineering of anisotropic nanostructures. IMPACT STATEMENTThis study developed a straightforward and general microfluidic platform to produce hollow nanostructures, providing new routes for rational design and engineering of functional nanomaterials. ARTICLE HISTORY

The emergence of microfluidic techniques provides new opportunities for chemicals synthesis and biomedical applications. Herein, we first develop a microfluidics-based flow and sustainable strategy to synthesize hierarchical silica-magnetic microflower with unique multilayered structure for the efficient capture of circulating tumor cells through our engineered microfluidic screening chip. The production of microflower materials can be realized within 94 milliseconds and a yield of nearly 5 grams per hour can be achieved. The enhanced bioaccessibility of such multilayered microflower toward cancer cells (MCF-7 and MDA-MB-231) is demonstrated, and the cancer cell capture efficiency of this hierarchical immunomagnetic system in clinical blood samples is significantly increased compared with standard CellSearch™ assay. These findings bring new insights for engineering functional micro-/nanomaterials in liquid biopsy.

Dynamically reconfigurable structural colors are promising materials for new smart optical systems. However, improved reflected color quality (e.g., saturation, optical contrast, angular invariance) and larger tuning range/sensitivity are needed. Here, we demonstrate a vibrant, actively tunable system which meets these needs via coupling broadband plasmonic resonators to a responsive polymer film. Our structure consists of near-percolation gold nanoislands deposited on a poly[methyl methacrylate] (PMMA) spacer above a gold mirror, forming a Fabry–Pérot nanocavity. Broadband absorption in this system creates vivid reflected colors, while the polymer spacer enables continuous tuning over a wide color space. By exploiting swelling effects in PMMA, we show fast, reversible color switching in response to organic vapors. Our sensitive optical structure amplifies small vapor-induced changes in the spacer thickness, enabling naked-eye detection of changes as small as 10 nm. Additionally, optical absorption >99% yields modulation contrasts up to 80:1, opening the door to ultra-sensitive on-chip signal measurements, complementing the visual colorimetric readout. This structure has immediate implications for colorimetric bio/chemical sensing and may also find application to reflective displays and flexible/adaptive optical coatings.